Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Enhancing Facial Nerve Neuroprotection and Regeneration Through Omega-3 Supplementation Following Vestibular Schwannoma Resection

NCT05116878 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT05116878
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05116878 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Enhancing Facial Nerve Neuroprotection and Regeneration Through Omega-3 Supplementation Following Vestibular Schwannoma Resection
Lead sponsor
Mayo Clinic
Phase
Not applicable
Overall status
Terminated
Start date
November 1, 2021
Completion date
August 2, 2023
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

vestibular schwannoma